Evommune, Inc.

Stock Chart, Company Information, and Scan Results

$13.23(as of Aug 28, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Evommune, Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$13.23

Ticker SymbolEVMN

ExchangeNyse

SectorHealthcare

IndustryBiotechnology

Employees48

CountyUSA

Market Cap$489.2M

EBIDTA-100.4M

10-Day Moving Average13.93

20-Day Moving Average13.78

Forward P/E Ratio0.00

50-Day Moving Average14.22

Earnings per Share-11.30

200-Day Moving Average20.09

Profit Margin0.00%

RSI45.30

Shares Outstanding36.3M

ATR0.89

52-Week High33.20

Volume350,600

52-Week Low10.47

Most Recent Support Level13.03

Most Recent Resistance Level14.44

Upper Keltner15.78

Lower Keltner11.79

Debt-to-Equity Ratio0.00

Next Earnings DateUnknown

Cash Surplus0.0M

Next Ex-Dividend DateUnknown

Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is headquartered in Palo Alto, California.

Evommune, Inc. In Our Stock Scanner

As of Aug 30, 2026

example chart graphic

Scan Name: Falling WedgeScan Type: Chart Pattern Scans

As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.